Lisa Fasone and her partner planned to have two children. Their dream seemed attainable with Fasone’s pregnancy in 2021, leading to the birth of their daughter in February 2022. However, postpartum challenges soon emerged.
Fasone experienced persistent symptoms including night sweats and headaches. Initially, she attributed these to breastfeeding and hormonal changes. After ceasing nursing for a year, Fasone became concerned as conception was still elusive and her menstrual cycle had not resumed.
Fasone decided to consult her OB-GYN. Tests revealed elevated prolactin levels, linked to a tiny benign pituitary tumor, known as a prolactinoma. This tumor was causing her symptoms.
Dr. Stephen McGill, a neurosurgeon at Northwestern University, explained that surgery for such tumors is rare. Typically, they are treated with medication, allowing the tumor to reduce or disappear.
Fasone started medication but faced severe dizziness. The medication was unsafe during pregnancy, raising concerns about her ability to conceive. Fasone felt challenged by the idea that she might remain a mother of one.
One year later, a scan showed her tumor had grown. Now pea-sized, it prompted consideration for surgery due to ongoing side effects and fertility concerns.
The procedure could impact the pituitary gland, yet for Fasone, it was worth the risk. The surgery offered hope for a cure and a medication-free life.
Fasone underwent a minimally invasive procedure in April 2025. The day after, her prolactin levels returned to normal. Her menstrual cycle resumed, signaling recovery.
Weeks later, Fasone discovered increased prolactin levels again, initially suggesting incomplete tumor removal. However, joyful news followed: she was pregnant.
In February 2026, Fasone welcomed another daughter, with her pregnancy progressing typically. Her hormones stabilized, enabling her to breastfeed.
Now, Fasone is back at work and has completed her doctorate in medical science. Her family, with two daughters, feels complete. McGill continues to monitor her prolactin levels and she will receive annual MRIs.
Fasone reflects on her journey from scheduling brain surgery to embracing motherhood. Her story underscores resilience and hope.
Leave a Reply